LEADER 05735nam 2200733Ia 450 001 9910455032603321 005 20200520144314.0 010 $a1-280-77105-4 010 $a9786613681829 010 $a1-84855-181-9 035 $a(CKB)1000000000767381 035 $a(EBL)453279 035 $a(OCoLC)609843571 035 $a(SSID)ssj0000357125 035 $a(PQKBManifestationID)11925369 035 $a(PQKBTitleCode)TC0000357125 035 $a(PQKBWorkID)10350959 035 $a(PQKB)11418635 035 $a(MiAaPQ)EBC453279 035 $a(Au-PeEL)EBL453279 035 $a(CaPaEBR)ebr10310683 035 $a(EXLCZ)991000000000767381 100 $a20081126d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aBeyond health insurance$b[electronic resource] $epublic policy to improve health /$fedited by Lorens Helmchen, Robert Kaestner, Anthony Lo Sasso 210 $aBingley $cJAI Press$d2008 215 $a1 online resource (219 p.) 225 1 $aAdvances in health economics and health services research,$x0731-2199 ;$vv. 19 300 $a"In light of the imbalance in health policy debate in the United States, in November 2007, the Institute of Government and Public Affairs and College of Medicine at the University of Illinois sponsored a conference entitled 'Beyond health insurance: public policy to improve health'--Introd. 311 $a1-84855-180-0 320 $aIncludes bibliographical references. 327 $aBeyond Health Insurance: Public Policy to Improve Health; Copyright page; Contents; List of contributors; Introduction; Reducing racial and ethnic disparities in health; Preventing disease and promoting health; Developing and regulating pharmaceuticals; Consumer information; Summary; Reference; Chapter 1. Quantifying national spending on wellness and prevention; Background; Methods; Results; Discussion; Notes; Acknowledgments; References; Chapter 2. Achieving the healthy people 2010 goal of elimination of health disparities: what will it takequest; Introduction 327 $aProgress in eliminating health disparitiesLimits of current strategy; Selecting policies; Early child intervention; Enhanced primary care within health centers; Conclusion; References; Chapter 3. Influence, information overload, and information technology in health care; 1. Introduction; 2. The diffusion of innovations in medicine; 3. Empirical evidence on the influence of computer-generated messages; 4. Influence and physician learning: a simple analytical framework; 5. Conclusion; Notes; References; Chapter 4. Health disparities and direct-to-consumer advertising of pharmaceutical products 327 $a1. Introduction2. Background on health disparities, use of pharmaceuticals, and DTC advertising; 3. Data on consumer exposure to television DTC advertisements; 4. Consumer exposure to DTC advertisements; 5. Conclusions; Notes; Acknowledgments; References; Chapter 5. Pharmaceutical innovation and the longevity of Australians: a first look; 1. Embodied technological progress hypothesis; 2. Econometric model; 3. Data sources and descriptive statistics; 4. Empirical results; 5. Summary and discussion; Notes; References; Chapter 6. Spillover effects of prescription drug withdrawals; Introduction 327 $aConceptual frameworkMethods; Data and empirical specification; Empirical results; Predicting negative spillovers or competitive benefits; Generalizability; Conclusions; Notes; Acknowledgments; References; Chapter 7. The psychology of nutrition messages; Introduction; Consumer cognition; The history of nutrition messages in the United States; Firm incentives to hijack; Research design and methods; Results; Further research; Policy implications; Conclusion; Notes; References; Chapter 8. Evaluation criteria for report cards of healthcare providers; Introduction 327 $aPotential benefits of report cardsPotential risks of report cards; Evaluation criteria for report cards; The bottom line: report cards - are the benefits worth the risksquest; References; Chapter 9. Evaluating the Value of Genomic Diagnostics: Implications for Clinical Practice and Public Policy; The advent of genomic diagnostics; Measuring value: the economic approach; Measuring value: the epidemiologic approach; Measuring value and the importance of clinical utility; A comprehensive framework of evaluating the value of genomic diagnostics 327 $aSome policy implications: an illustrative case study 330 $aMuch of the debate about health policy in the US has focused on the availability of health insurance coverage and the number of individuals who are uninsured. It is known that the United States spends approximately twice as much per capita on health care, 410 0$aAdvances in health economics and health services research ;$vv. 19. 606 $aMedical policy$zUnited States$vCongresses 606 $aHealth promotion$xGovernment policy$zUnited States$vCongresses 606 $aMedical informatics$zUnited States$vCongresses 606 $aPharmaceutical policy$zUnited States$vCongresses 608 $aElectronic books. 615 0$aMedical policy 615 0$aHealth promotion$xGovernment policy 615 0$aMedical informatics 615 0$aPharmaceutical policy 676 $a362.10973 676 $a362.11 701 $aHelmchen$b Lorens$0857299 701 $aKaestner$b Robert$0857300 701 $aLo Sasso$b Anthony T$g(Anthony Thomas)$0857301 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910455032603321 996 $aBeyond health insurance$91914240 997 $aUNINA